[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335249-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335249-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","adipocyte-derived-exosomes-promote-cell-invasion-and-challenge-paclitaxel-efficacy-in-ovarian-cancer","Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer","","Epithelial ovarian cancer is the most lethal gynecologic cancer, with high mortality driven by frequent resistance to chemotherapy. EOC commonly invades the omentum, an adipocyte-rich peritoneal organ, yet the signaling mechanisms behind omentum tropism remain unclear. The study applies 3D co-culture models to evaluate how adipocytes affect EOC proliferation, therapy response, and invasion, isolating patient-derived primary adipocytes and omentum-conditioned exosomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/adipocyte-derived-exosomes-promote-cell-invasion-and-challenge-paclitaxel-efficacy-in-ovarian-cancer/335249/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/adipocyte-derived-exosomes-promote-cell-invasion-and-challenge-paclitaxel-efficacy-in-ovarian-cancer/335249.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main clinical problem addressed in the paper?","Question",{"text":63,"@type":64},"The paper focuses on epithelial ovarian cancer that has high mortality largely due to chemotherapy resistance and late dissemination within the peritoneal cavity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do the authors study adipocyte–EOC interactions?",{"text":68,"@type":64},"They use three-dimensional co-culture models, isolating primary adipocytes and omental tissue from patients, then assessing how omentum-derived exosomes influence EOC proliferation, invasive capacity, and therapy response.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results show about omentum-derived exosomes and paclitaxel?",{"text":72,"@type":64},"Omentum-derived exosomes can induce an invasive phenotype via epithelial-to-mesenchymal transition, upregulate EMT markers, and reduce response to paclitaxel in EOC models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335249,1790019874,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Williams et al. Cell Communication and Signaling (2024) 22:443  \n[https://doi.org/10.1186/s12964-024-01806-4](https://doi.org/10.1186/s12964-024-01806-4)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nAdipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer  \nMichael Ellis Williams 1, David Howard 1, Claire Donnelly 1, Fereshteh Izadi 1, Jezabel Garcia Parra 1, Megan Pugh 1, Kadie Edwards 1, Kerryn Lutchman-Sigh2, Sadie Jones3, Lavinia Margarit 1,4, Lewis Francis 1, R. Steven Conlan 1, Francesca Taraball i5 and Deyarina Gonzalez 1*  \nAbstract  \nBackground Epithelial ovarian cancer (EOC) is the deadliest gynaecological cancer with high mortality rates driven by the common development of resistance to chemotherapy. EOC frequently invades the omentum, an adipocyterich organ of the peritoneum and omental adipocytes have been implicated in promoting disease progression, metastasis and chemoresistance. The signalling mechanisms underpinning EOC omentum tropism have yet to be elucidated.  \nMethods Three-dimensional co-culture models were used to explore adipocyte-EOC interactions. The impact of adipocytes on EOC proliferation, response to therapy and invasive capacity was assessed. Primary adipocytes andomental tissue were isolated from patients with ovarian malignancies and benign ovarian neoplasms. Exosomes were isolated from omentum tissue conditioned media and the effect of omentum-derived exosomes on EOC evaluated. Exosomal microRNA (miRNA) sequencing was used to identify miRNAs abundant in omental exosomes and EOC cells were transfected with highly abundant miRNAs miR-21, let-7b, miR-16 and miR-92a.  \nResults We demonstrate the capacity of adipocytes to induce an invasive phenotype in EOC populations through driving epithelial-to-mesenchymal transition (EMT) . Exosomes secreted by omental tissue of ovarian cancer patients, as well as patients without malignancies, induced proliferation, upregulated EMT markers and reduced response topaclitaxel therapy in EOC cell lines and HGSOC patient samples. Analysis of the omentum-derived exosomes from cancer patients revealed highly abundant miRNAs that included miR-21, let-7b, miR-16 and miR-92a that promoted cancer cell proliferation and protection from chemotherapy when transfected in ovarian cancer cells.  \nConclusions These observations highlight the capacity of omental adipocytes to generate a pro-tumorigenic and chemoprotective microenvironment in ovarian cancer and other adipose-related malignancies.  \nKeywords Ovarian cancer, Omentum, Adipocytes, Exosomes, miRNA, Mir-21, Prolactin, Obesity  \n*Correspondence: Deyarina Gonzalez [d.gonzalez@swansea.ac.uk](d.gonzalez@swansea.ac.uk)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nWilliams et al. Cell Communication and Signaling (2024) 22:443  \nBackground  \nEpithelial ovarian cancer (EOC) has the highest mortality rate of any gynaecological malignancy, with 5-year survival rates of less than 50%[1, 2]. This high mortality rate can be attributed to late presentatio","cbCaitqJ5CsKji29","https://ap.wps.com/l/cbCaitqJ5CsKji29","pdf",6646825,18,"English","# Abstract\n# Background\n## Chemotherapy resistance and late metastatic presentation\n## Omentum as a pro-metastatic niche and obesity link\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the main clinical problem addressed in the paper?\",\"answer\":\"The paper focuses on epithelial ovarian cancer that has high mortality largely due to chemotherapy resistance and late dissemination within the peritoneal cavity.\"},{\"question\":\"How do the authors study adipocyte–EOC interactions?\",\"answer\":\"They use three-dimensional co-culture models, isolating primary adipocytes and omental tissue from patients, then assessing how omentum-derived exosomes influence EOC proliferation, invasive capacity, and therapy response.\"},{\"question\":\"What do the results show about omentum-derived exosomes and paclitaxel?\",\"answer\":\"Omentum-derived exosomes can induce an invasive phenotype via epithelial-to-mesenchymal transition, upregulate EMT markers, and reduce response to paclitaxel in EOC models.\"}]","Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer | PDF",1790010296,45]